(secondQuint)A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques.

 This will be a 2-year, randomized, open-label, prospective, parallel-group study.

 It only be held in China-Japan Friendship Hospital.

 Subjects with Carotid Atherosclerosis Plaques who meet all inclusion and none of the exclusion criteria will be randomized in a 1:1 ratio to receive treatment of rosuvastatin (5 mg, 10mg, 20mg) dosing adjustment by LDL-c level or fixed dose 5 mg.

 The study will consist of two phases: the Screening/Baseline period(-1to week 0)and the Follow-up period(0 to month 24).

 The follow-up period will comprise seven visits.

.

 A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques@highlight

This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.

